C
Christopher C. Dvorak
Researcher at University of California, San Francisco
Publications - 251
Citations - 7345
Christopher C. Dvorak is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 41, co-authored 218 publications receiving 5430 citations. Previous affiliations of Christopher C. Dvorak include University of San Francisco & University of California.
Papers
More filters
Journal ArticleDOI
Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009
Sung-Yun Pai,Brent R. Logan,Linda M. Griffith,Rebecca H. Buckley,Roberta E. Parrott,Christopher C. Dvorak,Neena Kapoor,Imelda C. Hanson,Alexandra H. Filipovich,Soma Jyonouchi,Kathleen E. Sullivan,Trudy N. Small,Lauri Burroughs,Suzanne Skoda-Smith,Ann E. Haight,Audrey Grizzle,Michael A. Pulsipher,Ka Wah Chan,Ramsay Fuleihan,Elie Haddad,Brett Loechelt,Victor M. Aquino,Alfred P. Gillio,Jeffrey H. Davis,Alan P. Knutsen,Angela R. Smith,Theodore B. Moore,Marlis L. Schroeder,Frederick D. Goldman,James A. Connelly,Matthew H. Porteus,Qun Xiang,William T. Shearer,Thomas A. Fleisher,Donald B. Kohn,Jennifer M. Puck,Luigi D. Notarangelo,Morton J. Cowan,Richard J. O'Reilly +38 more
TL;DR: Transplants from donors other than matched siblings were associated with excellent survival among infants with SCID identified before the onset of infection.
Journal ArticleDOI
Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases.
Ana Burgos,Theoklis E. Zaoutis,Christopher C. Dvorak,Jill A. Hoffman,Katherine M. Knapp,Joseph J. Nania,Priya A. Prasad,William J. Steinbach +7 more
TL;DR: Immune reconstitution, rather than specific antifungal therapy, was found to be the best predictor of survival and common findings between adult and pediatric invasive aspergillosis were revealed.
Journal ArticleDOI
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience
William T. Shearer,Elizabeth Dunn,Luigi D. Notarangelo,Christopher C. Dvorak,Jennifer M. Puck,Brent R. Logan,Linda M. Griffith,Donald B. Kohn,Richard J. O'Reilly,Thomas A. Fleisher,Sung-Yun Pai,Caridad Martinez,Rebecca H. Buckley,Morton J. Cowan +13 more
TL;DR: In this article, the authors developed a uniform set of criteria for diagnosing SCID and related disorders and evaluated the results as part of a retrospective study of SCID in North America.
Journal ArticleDOI
Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.
Karin R. Engelhardt,Neil Shah,Intan Faizura-Yeop,Dilara Fatma Kocacık Uygun,Natalie Frede,Aleixo M. Muise,Eyal Shteyer,Serkan Filiz,Ronnie Chee,Mamoun Elawad,Britta Hartmann,Peter D. Arkwright,Christopher C. Dvorak,Christoph Klein,Jennifer M. Puck,Bodo Grimbacher,Bodo Grimbacher,Erik-Oliver Glocker +17 more
TL;DR: Because the defect in patients with IL-10/IL-10R deficiency resides in hematopoietic lineage cells and their colitis is resistant to standard immunosuppressive therapy, HSCT should be considered early as a potentially curative therapeutic option.
Journal ArticleDOI
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
Federica Barzaghi,Laura C. Amaya Hernandez,Benedicte Neven,Silvia Ricci,Zeynep Yesim Kucuk,Jack J. Bleesing,Zohreh Nademi,Mary Slatter,Erlinda R. Ulloa,Anna Shcherbina,Anna Roppelt,Austen Worth,Juliana Silva,Alessandro Aiuti,Luis Murguia-Favela,Carsten Speckmann,Magda Carneiro-Sampaio,Juliana Folloni Fernandes,Safa Baris,Ahmet Ozen,Elif Karakoc-Aydiner,Ayca Kiykim,Ansgar Schulz,Sandra Steinmann,Lucia Dora Notarangelo,Eleonora Gambineri,Paolo Lionetti,William T. Shearer,Lisa R. Forbes,Caridad Martinez,Despina Moshous,Stéphane Blanche,Alain Fisher,Frank M. Ruemmele,Come Tissandier,Marie Ouachée-Chardin,Frédéric Rieux-Laucat,Marina Cavazzana,Waseem Qasim,Barbarella Lucarelli,Michael H. Albert,Ichiro Kobayashi,Laura C. Alonso,Cristina Díaz de Heredia,Hirokazu Kanegane,Anita Lawitschka,Jong Jin Seo,Marta González-Vicent,Miguel Angel Diaz,Rakesh K. Goyal,Martin Sauer,Akif Yesilipek,Minsoo Kim,Yesim Yilmaz-Demirdag,Monica Bhatia,Julie Khlevner,Erick J. Richmond Padilla,Silvana Martino,Davide Montin,Olaf Neth,Agueda Molinos-Quintana,Justo Valverde-Fernandez,Arnon Broides,Vered Pinsk,Antje Ballauf,Filomeen Haerynck,Victoria Bordon,Catharina Dhooge,Maria Laura Garcia-Lloret,Robbert G. M. Bredius,Krzysztof Kałwak,Elie Haddad,Markus G. Seidel,Gregor Dückers,Sung-Yun Pai,Sung-Yun Pai,Christopher C. Dvorak,Stephan Ehl,Franco Locatelli,Frederick D. Goldman,Andrew R. Gennery,M.J. Cowan,Maria Grazia Roncarolo,Rosa Bacchetta +83 more
TL;DR: Patients receiving chronic IS were hampered by disease recurrence or complications, impacting long‐term disease‐free survival, and when performed in patients with a low OI score, HSCT resulted in disease resolution with better quality of life, independent of age, donor source, or conditioning regimen.